Klein Lawrence Otto — SEC insider filings
SEC reporting owner CIK 1762583. 29 insider filings on record with FilingPulse; latest filed 2026-11-02.
Transaction summary — filings shown
Covers all 29 filings on record, filed 2020-09-23 to 2026-11-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 29 legs across 8 filings — 255,910 shares, $29,979,965 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 61.
- Largest priced transaction: sale of 88,000 shares @ $128.20 ($11,281,600) in CRISPR Therapeutics AG, filed 2021-03-25.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| CRISPR Therapeutics AG (CRSP) | CBO & COO | 12 | — | 15 legs · 125,000 sh · $18,185,180 | 39 |
| Oruka Therapeutics, Inc. (ORKA) | Chief Executive Officer, Director | 8 | — | 14 legs · 130,910 sh · $11,794,785 | 9 |
| Dyne Therapeutics, Inc. (DYN) | Director | 4 | — | — | 8 |
| Jasper Therapeutics, Inc. (JSPR) | Director | 3 | — | — | 3 |
| Jade Biosciences, Inc. (JBIO) | Director | 2 | — | — | 2 |
Insider filings — Klein Lawrence Otto
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-02 | 4 | Oruka Therapeutics, Inc. (ORKA) | Option exercise (M): 25,000 @ $7.80 · Sale (S): 6,466 @ $94.77 · Sale (S): 15,036 @ $95.64 · Sale (S): 2,442 @ $96.70 · Sale (S): 756 @ $97.45 · Sale (S): 300 @ $98.40 · +1 more | EDGAR |
| 2026-10-02 | 4 | Oruka Therapeutics, Inc. (ORKA) | Option exercise (M): 25,000 @ $7.80 · Sale (S): 16,246 @ $83.40 · Sale (S): 8,554 @ $84.03 · Sale (S): 200 @ $84.78 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2026-09-15 | 4 | Oruka Therapeutics, Inc. (ORKA) | Sale (S): 2,452 @ $95.71 | EDGAR |
| 2026-09-01 | 4 | Oruka Therapeutics, Inc. (ORKA) | Option exercise (M): 75,000 @ $7.80 · Sale (S): 6,604 @ $90.79 · Sale (S): 63,596 @ $91.90 · Sale (S): 4,800 @ $92.44 · Option exercise (M): 75,000 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | Oruka Therapeutics, Inc. (ORKA) | Sale (S): 1,729 @ $69.69 | EDGAR |
| 2026-06-11 | 4 | Jade Biosciences, Inc. (JBIO) | Grant/award (A): 34,843 (derivative) @ $0 | EDGAR |
| 2026-03-17 | 4 | Oruka Therapeutics, Inc. (ORKA) | Sale (S): 1,729 @ $41.30 | EDGAR |
| 2026-01-23 | 4 | Oruka Therapeutics, Inc. (ORKA) | Grant/award (A): 76,700 @ $0 · Grant/award (A): 306,700 (derivative) @ $0 | EDGAR |
| 2025-05-01 | 4 | Jade Biosciences, Inc. (JBIO) | Grant/award (A): 23,017 (derivative) @ $0 | EDGAR |
| 2025-01-24 | 4 | Oruka Therapeutics, Inc. (ORKA) | Grant/award (A): 230,000 (derivative) @ $0 | EDGAR |
| 2023-06-08 | 4 | Jasper Therapeutics, Inc. (JSPR) | Grant/award (A): 47,000 (derivative) @ $0 | EDGAR |
| 2022-10-13 | 4 | Jasper Therapeutics, Inc. (JSPR) | Grant/award (A): 24,500 @ $0 | EDGAR |
| 2022-08-18 | 4 | CRISPR Therapeutics AG (CRSP) | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2022-07-06 | 4 | Dyne Therapeutics, Inc. (DYN) | Grant/award (A): 7,222 (derivative) @ $0 | EDGAR |
| 2022-06-06 | 4 | Dyne Therapeutics, Inc. (DYN) | Grant/award (A): 19,596 (derivative) @ $0 | EDGAR |
| 2022-03-23 | 4 | Jasper Therapeutics, Inc. (JSPR) | Grant/award (A): 78,045 (derivative) @ $0 | EDGAR |
| 2022-03-14 | 4 | CRISPR Therapeutics AG (CRSP) | Option exercise (M): 4,584 · Tax withholding (F): 1,883 @ $62.56 · Option exercise (M): 3,000 · Tax withholding (F): 1,229 @ $61.08 · Option exercise (M): 4,584 (derivative) · Option exercise (M): 3,000 (derivative) | EDGAR |
| 2022-02-22 | 4 | CRISPR Therapeutics AG (CRSP) | Grant/award (A): 46,200 (derivative) @ $0 · Grant/award (A): 20,400 (derivative) @ $0 | EDGAR |
| 2021-12-07 | 4 | CRISPR Therapeutics AG (CRSP) | Option exercise (M): 26,667 · Tax withholding (F): 11,185 @ $69.17 · Option exercise (M): 26,667 (derivative) | EDGAR |
| 2021-10-18 | 4 | CRISPR Therapeutics AG (CRSP) | Grant/award (A): 13,800 (derivative) @ $0 | EDGAR |
| 2021-09-14 | 4 | CRISPR Therapeutics AG (CRSP) | Option exercise (M): 10,000 · Tax withholding (F): 4,207 @ $117.86 · Tax withholding (F): 10,000 (derivative) | EDGAR |
| 2021-05-27 | 4 | Dyne Therapeutics, Inc. (DYN) | Grant/award (A): 19,596 (derivative) @ $0 | EDGAR |
| 2021-03-25 | 4 | CRISPR Therapeutics AG (CRSP) | Option exercise (M): 12,000 @ $44.67 · Option exercise (M): 22,000 @ $51.49 · Option exercise (M): 10,000 @ $29.87 · Option exercise (M): 20,000 @ $40.87 · Option exercise (M): 12,000 @ $14.43 · Option exercise (M): 12,000 @ $17.66 · +8 more | EDGAR |
| 2021-03-12 | 4/A | CRISPR Therapeutics AG (CRSP) | Option exercise (M): 16,334 @ $14.43 | EDGAR |
| 2021-03-12 | 4 | CRISPR Therapeutics AG (CRSP) | Option exercise (M): 4,583 · Tax withholding (F): 2,141 @ $124.15 · Grant/award (A): 33,334 (derivative) @ $0 · Grant/award (A): 12,000 (derivative) @ $0 | EDGAR |
| 2021-01-20 | 4 | CRISPR Therapeutics AG (CRSP) | Option exercise (M): 8,666 @ $12.57 · Sale (S): 2,911 @ $211.44 · Sale (S): 2,555 @ $212.54 · Sale (S): 1,200 @ $213.71 · Sale (S): 1,400 @ $214.46 · Sale (S): 400 @ $216.24 · +11 more | EDGAR |
| 2021-01-04 | 4 | CRISPR Therapeutics AG (CRSP) | Tax withholding (F): 9,392 @ $153.11 | EDGAR |
| 2020-10-06 | 4 | CRISPR Therapeutics AG (CRSP) | Grant/award (A): 16,666 (derivative) @ $0 | EDGAR |
| 2020-09-23 | 4 | Dyne Therapeutics, Inc. (DYN) | Conversion (C): 10,725 · Grant/award (A): 11,156 (derivative) @ $0 · Grant/award (A): 14,444 (derivative) @ $0 · Purchase (P): 35,574 (derivative) @ $2.81 · Conversion (C): 35,574 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-21 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1762583 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs